Abstract
Introduction
Obesity is a fast growing social problem that is reaching epidemic expansion worldwide [1] . Primary defects in energy balance that produce obesity and visceral adiposity in particular are sufficient to drive all aspects of metabolic syndrome including insulin resistance, glucose intolerance, hypertension and dyslipidaemia [2] . Obesity is associated with increased levels of circulating free fatty acid (FFA) and other secreted factors that can provoke peripheral insulin resistance in both animals and human beings [3] . Increased availability of FFA derived from adipose tissue also accelerate hepatic synthesis of very low density lipoproteins (VLDL), contributing to dyslipidaemia [4] . Importantly, a majority of studies have demonstrated that even modest weight gain can precipitate the onset of hypertension [5] . Individuals with a central deposition of adipose tissue can experience elevated cardiovascular morbidity and mortality, including stroke, congestive heart failure, myocardial infarction and cardiovascular death [6, 7] . Therefore, to elucidate the underlying mechanisms that link obesity to endothelial dysfunction and cardiovascular diseases has been a focus of studies for the past decades [8] .
Apolipoprotein A-I (ApoA-I) is the most abundant protein constituent of high-density lipoprotein (HDL) [9, 10] . Previous studies have demonstrated that the blood level of ApoA-I is more closely correlated with the risk of atherosclerosis than other markers such as HDL-cholesterol [11] . In addition to their anti-atherogenic function, recent studies have indicated that HDL and ApoA-I are inversely correlated to the development of obesity [12] . Obesity has been shown to be associated with a reduced plasma ApoA-I level [13] . Another study indicates that the reduced HD level in intra-abdominal obese patients is partly caused by an increased clearance rate of ApoA-I [14] . It was recently reported that ApoA-I gene polymorphisms are risk factors for hypertension and obesity [15] . Study in animals also demonstrated that ApoA-I-deficient mice had an increased fat content [16] [19, 20] . D-4F also increases antioxidants and improves vascular repair in type 1 diabetic rats [21] . In addition, it has been shown that D-4F could improve vasodilation, oxidative stress, myocardial inflammation and angiogenic potential in a mouse model of scleroderma [22] . D-4F also reduces renal inflammation in low-density lipoprotein (LDL) receptor-null mice [23] , ameliorates collagen-induced arthritis in rat [24] and improves the inflammatory properties of HDL in human beings with coronary heart disease [25] .
We [28] . 
Analysis of serum parameters

The serum total cholesterol, triglyceride, HDL cholesterol and LDL cholesterol were determined by kits from Sysmex (Shanghai, China). The serum FFA was determined by a kit from Roche Diagnostics Corporation (Indianapolis, IN, USA). The serum insulin level was determined by a radioimmunoassay (BNIBT, Beijing, China).
Studies of metabolic profile of the mouse
After the mouse was acclaimed to a powdered high-fat diet, the metabolic profile of the animal was measured, including food intake, oxygen consumption, carbon dioxide production, respiratory exchange ratio (RER) and locomotive movement in metabolic cages (Columbus Instruments, Columbus, OH, USA). The calculated metabolic rate (Weir equation) is expressed per gram body weight
Real-time quantitative RT-PCR analysis
Brown fat precursor cell isolation and culture
Brown fat precursor cells were isolated from 6-8-week-old male C57BL/6J mice as previously described [29] (Fig. 2C) . In addition, the weight of epididymal fat pad was significantly lower in D-4F-treated mice than the control animals (Fig. 2D) (Figs 1 and 2 ). (Figs 1 and 2 Fig. 7A and B) . Importantly, treatment of the cells with ApoA-I or D-4F also led to significant increase of both UCP1 mRNA and protein in these cells (Fig. 7A and B (Fig. 7C) , similar to the findings in endothelial cells and myocytes [16, 34] .
ApoA-I mimetic peptide D-4F reduces HFD-induced obesity
ApoA-I and D-4F enhance energy expenditure in the mouse
The reduction of fat accumulation in ApoA-I-Tg and D-4F-treated mice versus the control animals upon HFD feeding was not associated with a reduction of food intake
Discussion
As the most abundant protein constituent of HDL, ApoA-I has been a focus of studies in the past to elucidate the anti-atherogenic effects of HDL [9] . However, a few recent studies have linked ApoA-I to glucose and energy metabolism, revealing that ApoA-I can stimulate AMPK in different cells [16, 34] [35] . The importance of brown fat tissues in human beings are highlighted by recent discoveries that brown fat can be detected in adult human beings [36, 37] . Most importantly, the amount of brown adipose tissue is inversely correlated with body-mass index [38] 
